Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1997 1
2001 1
2002 1
2006 1
2007 4
2008 3
2009 2
2010 2
2011 1
2012 3
2013 2
2014 2
2015 3
2016 3
2017 7
2018 4
2019 3
2020 1
2021 5
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm.
Chelliah V, Lazarou G, Bhatnagar S, Gibbs JP, Nijsen M, Ray A, Stoll B, Thompson RA, Gulati A, Soukharev S, Yamada A, Weddell J, Sayama H, Oishi M, Wittemer-Rump S, Patel C, Niederalt C, Burghaus R, Scheerans C, Lippert J, Kabilan S, Kareva I, Belousova N, Rolfe A, Zutshi A, Chenel M, Venezia F, Fouliard S, Oberwittler H, Scholer-Dahirel A, Lelievre H, Bottino D, Collins SC, Nguyen HQ, Wang H, Yoneyama T, Zhu AZX, van der Graaf PH, Kierzek AM. Chelliah V, et al. Among authors: zutshi a. Clin Pharmacol Ther. 2021 Mar;109(3):605-618. doi: 10.1002/cpt.1987. Epub 2020 Aug 14. Clin Pharmacol Ther. 2021. PMID: 32686076 Free PMC article. Review.
Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data.
Kareva I, Zutshi A, Mateo CV, Papasouliotis O. Kareva I, et al. Among authors: zutshi a. Eur J Drug Metab Pharmacokinet. 2021 Sep;46(5):601-611. doi: 10.1007/s13318-021-00706-z. Epub 2021 Jul 30. Eur J Drug Metab Pharmacokinet. 2021. PMID: 34328632 Free PMC article. Review.
Response rate of lorazepam in catatonia: a developing country's perspective.
Tibrewal P, Narayanaswamy J, Zutshi A, Srinivasaraju R, Math SB. Tibrewal P, et al. Among authors: zutshi a. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1520-2. doi: 10.1016/j.pnpbp.2010.08.017. Epub 2010 Sep 8. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20804808
Gender Differences in Persistent Delusional Disorder.
Kulkarni KR, Arasappa R, Prasad MK, Zutshi A, Chand PK, Murthy P, Muralidharan K. Kulkarni KR, et al. Among authors: zutshi a. Indian J Psychol Med. 2017 Mar-Apr;39(2):216-217. doi: 10.4103/0253-7176.203123. Indian J Psychol Med. 2017. PMID: 28515568 Free PMC article. No abstract available.
45 results